Clinical Trials Directory

Trials / Unknown

UnknownNCT05719181

Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.

Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study of 6\12\2021 to20\4\2023

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
University of Baghdad · Academic / Other
Sex
All
Age
25 Years – 70 Years
Healthy volunteers
Accepted

Summary

Effect of Recombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.

Detailed description

The Primary outcome will be measuring the effect of rhBMP- 2/ACS in improving the secondary stability of dental implant by using RFA in comparison to control group. Secondary outcome association of the effect of other factors (ridge dimension, bone density) on dental implant stability.

Conditions

Interventions

TypeNameDescription
BIOLOGICALrhBMP-2Recombinant Human Bone Morphogenetic Protein-2 with an Absorbable Collagen Sponge .

Timeline

Start date
2021-12-06
Primary completion
2023-03-18
Completion
2023-04-20
First posted
2023-02-08
Last updated
2023-02-08

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT05719181. Inclusion in this directory is not an endorsement.